Product Information
CARBAMAZEPINE ER 200 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.3776 per EA under NDC 59746079001. Its NADAC has been published 185 times since Feb 8, 2023.
FDA first approved this application on Aug 18, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746079001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA216594FDA Approved
8/18/2022
TE Code
AB
On Market Since
8/20/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE ER 200 MG TABLET has been published 185 times since Feb 8, 2023, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3776 per EA |
|---|---|
| All-time high | $0.7248 (Apr 12, 2023) |
| All-time low | $0.2489 (Nov 20, 2024) |
| 52-week high | $0.4219 |
| 52-week low | $0.3488 |
| Median price | $0.4365 |
| Average price | $0.4705 |
| Largest weekly change | +79.9% (Jun 19, 2024) |
| Weeks tracked | 185 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 69% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE ER 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 200 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.3776 per EA (NDC 59746079001), effective Aug 19, 2026.
How has the price of CARBAMAZEPINE ER 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE ER 200 MG TABLET has declined 36.9%. It has been tracked across 185 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 200 MG TABLET?
Since Feb 8, 2023, the NADAC for CARBAMAZEPINE ER 200 MG TABLET has ranged from a low of $0.2489 (Nov 20, 2024) to a high of $0.7248 (Apr 12, 2023), with a median of $0.4365 per EA.
Are there cheaper alternatives to CARBAMAZEPINE ER 200 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPITOL 200 MG TABLET, is $0.1170 per EA — about 69% below CARBAMAZEPINE ER 200 MG TABLET.
Who manufactures CARBAMAZEPINE ER 200 MG TABLET?
CARBAMAZEPINE ER 200 MG TABLET (NDC 59746079001) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.